ISP-16-4 Doxorubicin hydrochloride and Bevacizumab for the patients with Platinum-taxane resistant ovarian cancer(Group 16 Ovarian Cancer 5,International Session Poster) :
-
- Ota,Tsuyoshi
- Juntendo University
-
- Fujino,Kazunari
- Juntendo University
-
- Ujihira,Takafumi
- Juntendo University
-
- Kusunoki,Soshi
- Juntendo University
-
- Sugimori,Yayoi
- Juntendo Nerima Hospital
-
- Kaneda,Hiroshi
- Juntendo University
-
- Kimura,Miki
- Juntendo University
-
- Terao,Yasuhisa
- Juntendo University
-
- Ogishima,Daiki
- Juntendo Nerima Hospital
-
- Itakura,Atsuo
- Juntendo University
-
- Takeda,Satoru
- Juntendo University
Search this article
Journal
-
- 日本産科婦人科學會雜誌
-
日本産科婦人科學會雜誌 68 (2), 523-, 2016-02-01
日本産科婦人科学会
- Tweet
Details 詳細情報について
-
- CRID
- 1540291245366428928
-
- NII Article ID
- 110010034681
-
- NII Book ID
- AN00190060
-
- Text Lang
- en
-
- Data Source
-
- NDL-Digital
- CiNii Articles
